Bifidogenic effect of fructooligosaccharides in the intestinal flora of patients with hematological neoplasia;Efeito bifidogênico do frutooligossacarídeo na microbiota intestinal de pacientes com neoplasia hematológica

Revista de Nutricao

Volumn 20, Issue 5, 2007, Pages 491-497

  Búrigo, Telma ^a   Fagundes, Regina Lúcia Martins ^b   Trindade, Erasmo Benicio Santos De Moraes ^b   Vasconcelos, Helena Cristina Ferreira Franz ^b  

^a Departamento de Anestesia   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Bifidogenic microbiota; Fructooligosaccharide; Hematologic neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; FRUCTOSE OLIGOSACCHARIDE; MALTODEXTRIN;

ADULT; ARTICLE; BIFIDOBACTERIACEAE; BLOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FECES ANALYSIS; FEMALE; HUMAN; INTESTINE FLORA; MALE; PH MEASUREMENT; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION;

EID: 36849049142     PISSN: 14155273     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1415-52732007000500005     Document Type: Article

References (26)

1. Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The intelligent intestine", held in Paris. Am J Clin Nutr. 2003; 78: 675-83.
2. Gibson GR, Roberfroid MB. Dietary modulation of human colonic microbiota: introducing the concept of the prebiotics. J Nutr. 1995; 125:1401-12.
3. Berg R. The indigenous gastrointestinal microflora. Trends Microbiol. 1996; 4(11):430-5.
4. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998; 42:2-7.
5. Blaut, M. Relationship of probiotics and food to intestinal microflora. Eur J Nutr. 2002; 41(Suppl 1):11-6.
6. Bengmark S. Immunonutrition: role of biosurfactants fiber and probiotic bacteria. Nutrition. 1998; 14(7/8):585-94.
7. Guarner F. El colon como órgano: hábitat de flora bacteriana. Nutr Hosp. 2002; (Suppl 2):2-7.
8. Peris GP, Lesmes B, Cuerda Compes CM, Álvarez C. Metabolismo colônico de la fibra. Nutr Hosp. 2002; 17:11-6.
9. Leahy SC, Higgins DG, Fitzgerald, Sinderen D van. A review: getting better with bifidobacterium. J Appl Microbiol. 2005; 98:1303-15.
10. Ishibashi N, Yaeshima T, Hayasawa H. Bifidobacteria: their significance in human intestinal health. Mal J Nutr. 1997; 3:149-59.
11. Guarner F, Malagelada JR. Gut flora in health and disease. The Lancet. 2003; 361(8):512-9.
12. Hopkins MJ, MacFarlane GT. Nondisgestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl Env Microbiol. 2003; 69(4):1920-7.
13. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of the colonic bacteria. J Appl Bacteriol. 1994; 77(4):412-20.
14. Gibson GR. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr. 1999; 129:1438-41s.
15. Nucci M. Infecções no paciente com neoplasia hematológica: diagnóstico, tratamento e prevenção. In: Zago MA, Falcão RP, Pasquini R. Hematologia: fundamentos e prática. São Paulo: Atheneu; 2001. cap.44:419-29.
16. Daly JM, Hoffman K, Lieberman M, Leon P, Redmond HP, Shou J, et al. Nutritional support in the cancer patient. JPEN. 1990; 14(5):244-8s.
17. Watzl B, Girrbacch S, Roller M. Inulin, oligofructose and immunomodulation. Br J Nutr. 2005; 93(Suppl 1): 49-55.
18. Cummings JH, Macfarlane GT, Englist HN. Prebiotics digestion and fermentation. Am J Clin Nutr. 2001; 73(Suppl):415-20.
19. Bengmark S, Lorenzo AG, Culebras MJ. Use of pro, pre and symbiotics in the ICU-future options. Nutr Hosp. 2001; 16(6):239-56.
20. Cummings JH, MacFarlane GT. Gastrointestinal effects of prebiotics. Br J Nutr. 2002; 87(Suppl 2):145-51.
21. Muñoa FJ, Pares R. Selective medium for isolation and enumeration of bifidobacterium spp. Appl Envl Microbiol. 1988; 54(7):1715-8.
22. Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, et al. Recombinant human interleukin 11 and bacterial infection in patient with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomized trial. Lancet. 2003; 361(25):275-80.
23. Bouhnik Y, Flourié B, Abensour DA, Pochart P, Gramet G, Durand M, et al. Administration transgalacto-oligosaccharides increases fecal bifidobactéria and modifies colonic fermentation metabolism in healthy humans. J Nutr. 1997; 127:444-8.
24. Kleessen B, Sykura B, Zunfit HJ, Blaut M. Effect of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr. 1997; 65:1397-02.
25. Gibson GR. Fiber and effect on prebiotics (The prebiotic concept). Clin Nutr Suppl. 2004; 1:25-31.
26. Garro MS, Aguirre L, Giori GS. Biological activity of bifidobacterium longum in response to environmental pH. Appl Microbiol Biotechnol. 2005; (7):92-7.